Opendata, web and dolomites
H2020 projects about "iia"
The page lists 27 projects related to the topic "iia".
| # | |||
|---|---|---|---|
| 1 | AdvancedStarForm | Global and local star formation with state-of-the-art physics | 2015 |
| 2 | NOVENA | Exploiting an unusual polyketide chain release mechanism for production of novel enacyloxin antibiotic analogues | 2015 |
| 3 | AML-VACCiN | Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia | 2016 |
| 4 | STIPED | Transcranial brain stimulation as innovative therapy for chronic pediatric neuropsychiatric disorder – STIPED | 2017 |
| 5 | HIVACAR | Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection | 2017 |
| 6 | INNOBCT | Innovative combination therapy against bladder cancer | 2017 |
| 7 | AMPK-DIAB | A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novelinnovative drug for the treatment of type 2 diabetes | 2016 |
| 8 | Renaparin | Improving kidney transplantation outcome with Renaparin® for patients with End-Stage Renal Disease by attenuating graft ischemia reperfusion injury | 2017 |
| 9 | GAIT | From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy | 2017 |
| 10 | PARK-IT 2.0 | Unobtrusive, Continuous and Quantitative Assessment of Parkinson’s disease: Hard Evidence for Optimal Disease Management with Information Technologies | 2017 |
| 11 | BLMs 4 TB | Beta-lactams for Tuberculosis Treatment | 2018 |
| 12 | IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease | 2017 |
| 13 | SYN1002 | A New Therapeutic Option to Protect Central Nervous System against Acute Ischemic Stroke | 2017 |
| 14 | EDGE | European Direction in GEOSS Common Infrastructure Enhancements | 2017 |
| 15 | CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | 2017 |
| 16 | RheumArth | New drug for the treatment of rheumatoid arthritis | 2018 |
| 17 | EpiGlioT | Epigenetic Glioblastoma Therapeutics | 2018 |
| 18 | iProg | Tailored cell-based therapies for frontotemporal dementia and related genetically defined CNS orphan indications | 2018 |
| 19 | TOL2 | An effective and safe targeted therapy for treatment of Myasthenia gravis | 2018 |
| 20 | AllergyVAX | Next generation allergen immunotherapy based on specifically modified recombinant hypoallergens | 2018 |
| 21 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
| 22 | DIABETESMART | The first Clinically Validated AI-powered Diabetes Assistant | 2019 |
| 23 | TRS | A paradigm change in the treatment of blinding ocular diseases | 2019 |
| 24 | HEPHAESTUS | Heating Electric-fields in a Plasma CVD reactor to Heighten Ability to grow Eeco-friendly and Sublime Type IIA Diamonds (which are Unique Stones) | 2019 |
| 25 | TIR-C | NEXT GENERATION TOPICAL MEDICATION TO TREAT IMMUNE RESPONSES IN ATOPIC DERMATITIS – THE MOST COMMON CAUSE OF ECZEMA | 2019 |
| 26 | TherVacB | THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B | 2020 |
| 27 | INDIGO | Effective and Affordable Flu Vaccines for the World | 2020 |